This paper examines the existing literature and MedWatch reports concerning
a proposed relationship between isotretinoin and depression and suicide. T
he authors provide a brief overview of the biology of isotretinoin and depr
essive disorder and find no basis for a putative molecular mechanism linkin
g the two. They also address the complexities of Substance-Induced Mood Dis
order (SIMD)asa psychiatric diagnosis and its relevance to isotretinoin. Ba
sed on this review, the authors conclude that there is no evidence to suppo
rt a causal connection between isotretinoin and major depression Or suicide
, because reported cases do not meet the established criteria for causality
, The authors also conclude, however, that it is important for dermatologis
ts to be aware of the risk factors for suicide and to monitor patients who
exhibit depressive symptoms.